These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma. Granfors T; Tomic R; Ljungberg B Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744 [TBL] [Abstract][Full Text] [Related]
10. What is the significance of pT0 at cystectomy? Hotston M; Patel S; Sohail M; Persad RA Surg Oncol; 2006 Aug; 15(2):65-9. PubMed ID: 16971115 [TBL] [Abstract][Full Text] [Related]
11. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder. Potretzke A; Hillman L; Wong K; Shi F; Brower R; Mai S; Cetnar JP; Abel EJ; Downs TM Urol Oncol; 2014 Jul; 32(5):631-6. PubMed ID: 24629498 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy. Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398 [TBL] [Abstract][Full Text] [Related]
13. External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Nuhn P; May M; Fritsche HM; Buchner A; Brookman-May S; Bolenz C; Moritz R; Herrmann E; Burger M; Höfner T; Ellinger J; Tilki D; Roigas J; Zacharias M; Trojan L; Wülfing C; May F; Melchior S; Haferkamp A; Gilfrich C; Hohenfellner M; Wieland WF; Müller SC; Stief CG; Bastian PJ Eur J Surg Oncol; 2012 Jul; 38(7):637-42. PubMed ID: 22459902 [TBL] [Abstract][Full Text] [Related]
14. Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder. Singh PB; Kumar A; Das SK; Pandey AK; Sharma GK; Samir Swain HB; Trivedi S; Dwivedi US Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):881-5. PubMed ID: 20814125 [TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder. May M; Bastian PJ; Burger M; Bolenz C; Trojan L; Herrmann E; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Otto W; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Wieland WF; Fritsche HM BJU Int; 2011 Oct; 108(8 Pt 2):E278-83. PubMed ID: 21699644 [TBL] [Abstract][Full Text] [Related]
16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
17. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. May M; Nitzke T; Helke C; Vogler H; Hoschke B Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377 [TBL] [Abstract][Full Text] [Related]
18. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Lotan Y; Vazina A; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; J Urol; 2006 May; 175(5):1645-9; discussion 1649. PubMed ID: 16600721 [TBL] [Abstract][Full Text] [Related]
19. Are bladder cancer patients with pT0 disease following radical cystectomy cured of cancer? Thalmann G Nat Clin Pract Urol; 2006 Oct; 3(10):530-1. PubMed ID: 17031377 [No Abstract] [Full Text] [Related]
20. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]